Identification of key residues that confer Rhodobacter sphaeroides LPS activity at horse TLR4/MD-2

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Irvine, Katherine L ^a   Gangloff, Monique ^a   Walsh, Catherine M ^a   Spring, David R ^a   Gay, Nicholas J ^a   Bryant, Clare E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DIMER; LIGAND; LIPID; LIPID A; LIPID IVA; PROLINE; PROTEIN MD 2; SERINE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; LY96 PROTEIN, HUMAN; PROTEIN BINDING; TLR4 PROTEIN, HUMAN;

ARTICLE; CARBOHYDRATE ANALYSIS; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; GENE MUTATION; HORSE; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DOCKING; NONHUMAN; PROTEIN FUNCTION; RESIDUE ANALYSIS; RHODOBACTER SPHAEROIDES; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; GENETICS; HEK293 CELL LINE; METABOLISM; MUTAGENESIS; SPECIES DIFFERENCE;

ANIMALS; CELL LINE; HEK293 CELLS; HORSES; HUMANS; LIGANDS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MUTAGENESIS; PROTEIN BINDING; RHODOBACTER SPHAEROIDES; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TOLL-LIKE RECEPTOR 4;

EID: 84902349981     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098776     Document Type: Article

References (25)

1. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
2. Poltorak A, Smirnova I, He X, Liu M, Van Huffel C, et al. (1998) Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 24: 340-355. (Pubitemid 28524834)
3. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, et al. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. JExp Med 189: 1777-1782. (Pubitemid 29272694)
4. Park B, Song D, Kim H, Choi B, Lee H, et al. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458: 1191-1195.
5. Ohto U, Fukase K, Miyake K, Shimizu T (2012) Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc Natl Acad Sci U S A 109: 7421-7426.
6. Meng J, Drolet J, Monks B, Golenbock D (2010) MD-2 residues tyrosine 42, arginine 69, aspartic acid 122, and leucine 125 provide species specificity for lipid IVA. J Biol Chem 285: 27935-27943.
7. Golenbock D, Hampton R, Qureshi N, Takayama K, Raetz C (1991) Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 266: 19490-19498. (Pubitemid 21908258)
8. Lohmann K, Vandenplas M, Barton M, Moore J (2003) Lipopolysaccharide from Rhodobacter sphaeroides is an agonist in equine cells. J Endotoxin Res 9: 33-37. (Pubitemid 36322482)
9. Walsh C, Gangloff M, Monie T, Smyth T, Wei B, et al. (2008) Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J Immunol 181: 1245-1254.
10. Kim H, Park B, Kim J, Kim S, Lee J, et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-917. (Pubitemid 47332573)
11. Ohto U, Fukase K, Miyake K, Satow Y (2007) Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316: 1632-1634. (Pubitemid 46982039)
12. Resman N, Vasl J, Oblak A, Pristovsek P, Gioannini T, et al. (2009) Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin. J Biol Chem 284: 15052-15060.
13. Qureshi N, Honovich J, Hara H, Cotter R, Takayama K (1988) Location of fatty acids in lipid A obtained from lipopolysaccharide of Rhodopseudomonas sphaeroides ATCC 17023. J Biol Chem 263: 5502-5504.
14. Lohmann K, Vandenplas M, Barton M, Bryant C, Moore J (2007) The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist. J Endotoxin Res 13: 235-242. (Pubitemid 47618262)
15. Walsh C (2008) Contributions of equine TLR4 and MD-2 to lipid A discrimination. Ph.D. thesis, University of Cambridge.
16. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815. (Pubitemid 24007801)
17. Eisenberg D, Luthy R, Bowie JU (1997) VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol 277: 396-404.
18. Chen VB, Arendall WB, 3rd, Headd JJ, Keedy DA, Immormino RM, et al. (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66: 12-21.
19. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, et al. (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791.
20. Omueti K, Beyer J, Johnson C, Lyle E, Tapping R (2005) Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 280: 36616-36625. (Pubitemid 41587738)
21. Figueroa L, Xiong Y, Song C, Piao W, Vogel S, et al. (2012) The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF. J Immunol 188: 4506-4515.
22. Stevens CW, Aravind S, Das S, Davis RL (2013) Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4. Br J Pharmacol 168: 1421-1429.
23. Prohinar P, Re F, Widstrom R, Zhang D, Teghanemt A, et al. (2007) Specific high affinity interactions of monomeric endotoxin.protein complexes with Toll-like receptor 4 ectodomain. J Biol Chem 282: 1010-1017. (Pubitemid 47076551)
24. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, et al. (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6: 565-570. (Pubitemid 41710726)
25. Meng J, Lien E, Golenbock D (2010) MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J Biol Chem 285: 8695-8702.